Brief Report: HIV-1 Seroconversion Is Not Associated With Prolonged Rectal Mucosal Inflammation

Area of Science:

• Immunology
• Virology
• Public Health

Background:

• Rectal mucosa is a primary site for HIV-1 infection and inflammation.
• Understanding the impact of HIV-1 seroconversion on local immune responses is crucial for prevention and treatment strategies.

Purpose of the Study:

• To determine the effect of HIV-1 seroconversion on inflammatory cytokine levels in the rectal mucosa.
• To investigate potential links between rectal inflammation and HIV acquisition in high-risk populations.

Main Methods:

• A secondary analysis of data from a HIV prevention trial involving men who have sex with men and transgender women in Lima, Peru.
• Rectal secretions were collected via sponge to measure inflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α).
• Participants were screened for HIV and rectal gonorrhea/chlamydia at baseline, 3, and 6 months; statistical tests compared cytokine levels between HIV-seroconverters and HIV-negative individuals.

Main Results:

• Eight participants seroconverted to HIV during the study period.
• No significant differences in rectal inflammatory cytokine levels were observed between participants who did and did not experience HIV seroconversion.
• Receptive anal intercourse frequency did not differ between HIV-seroconverters and non-converters prior to HIV diagnosis.

Conclusions:

• HIV-1 seroconversion does not appear to have a prolonged impact on inflammatory cytokine levels in the rectal mucosa.
• These findings suggest that acute HIV infection may not lead to sustained rectal mucosal inflammation.
• Further research may explore other factors influencing rectal inflammation in the context of HIV infection.